Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Free Cash Flow (2019 - 2025)

Historic Free Cash Flow for IDEAYA Biosciences (IDYA) over the last 7 years, with Q4 2025 value amounting to -$90.8 million.

  • IDEAYA Biosciences' Free Cash Flow rose 2600.91% to -$90.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$73.5 million, marking a year-over-year increase of 7078.2%. This contributed to the annual value of -$73.5 million for FY2025, which is 7078.2% up from last year.
  • Latest data reveals that IDEAYA Biosciences reported Free Cash Flow of -$90.8 million as of Q4 2025, which was up 2600.91% from $142.2 million recorded in Q3 2025.
  • In the past 5 years, IDEAYA Biosciences' Free Cash Flow ranged from a high of $142.2 million in Q3 2025 and a low of -$122.8 million during Q4 2024
  • Moreover, its 5-year median value for Free Cash Flow was -$26.9 million (2022), whereas its average is -$29.6 million.
  • Per our database at Business Quant, IDEAYA Biosciences' Free Cash Flow plummeted by 39929.63% in 2024 and then skyrocketed by 38611.22% in 2025.
  • Quarter analysis of 5 years shows IDEAYA Biosciences' Free Cash Flow stood at -$17.3 million in 2021, then plummeted by 35.38% to -$23.4 million in 2022, then dropped by 5.2% to -$24.6 million in 2023, then tumbled by 399.3% to -$122.8 million in 2024, then rose by 26.01% to -$90.8 million in 2025.
  • Its Free Cash Flow stands at -$90.8 million for Q4 2025, versus $142.2 million for Q3 2025 and -$63.1 million for Q2 2025.